Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.
Authors: Termini R; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Žihala D; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic., Terpos E; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Perez-Montaña A; Hospital Universitario Son Espases, Palma, Spain., Jelínek T; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic., Raab M; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Weinhold N; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Mai EK; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Grab AL; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Corre J; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France., Vergez F; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France., Sacco A; ASST Spedali Civili di Brescia, Brescia, Italy., Chiarini M; ASST Spedali Civili di Brescia, Brescia, Italy., Giustini V; ASST Spedali Civili di Brescia, Brescia, Italy., Tucci A; ASST Spedali Civili di Brescia, Brescia, Italy., Rodriguez S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Moreno C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Perez C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Maia C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Martín-Sánchez E; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Guerrero C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Botta C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Garces JJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Lopez A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Tamariz-Amador LE, Prosper F; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Bargay J; Hospital Sont LLatzer, Palma de Mallorca, Spain., Cabezudo ME; Hospital de Sant Joan Despí Moisès Broggi/ICO-H, Barcelona, Spain., Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain., Hájek R; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic., Martinez-Lopez J; Hospital Universitario 12 De Octubre, Universidad Complutense, CNIO Madrid, Spain., Solano F; Hospital Ntra Sra del Prado, Talavera De La Reina, Spain., Iglesias R; MD Anderson Cancer Center, Madrid, Spain., Paiva A; Flow Cytometry Unit (UGOC), Department of Clinical Pathology, Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal., Geraldes C; Flow Cytometry Unit (UGOC), Department of Clinical Pathology, Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal., Vitoria H; Centro Hospitalare Universitário de Coimbra (CHUC), Coimbra, Portugal., Gomez C; Hospital de Galdakao, Vizcaya, Spain., De Arriba F; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain., Ludwig H; Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna, Austria., Garcia-Guiñon A; Hospital Universitario Arnau de Vilanova, Lleida, Spain., Casanova M; Hospital Costa del Sol Marbella, Marbella, Spain., Alegre A; Hospital de la Princesa, Madrid, Spain., Cabañas V; Hospital Virgen de la Arrixaca de Murcia, IMIB Arrixaca, Universidad de Murcia, Murcia, Spain., Sirvent M; Hospital Universitario de Donostia, San Sebastián, Spain., Oriol A; Institut Català d'Oncologia Institut Josep Carreras, Badalona, Spain., de la Rubia J; University Hospital de La Fe, School of Medicine and Dentistry, Catholic University of Valencia, CIBERONC CB16/12/00284, Valencia, Spain., Hernández-Rivas JÁ; Hospital Universitario Infanta Leonor, Departamento de Medicina, Universidad Complutense, Madrid, Spain., Palomera L; Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain., Sarasa M; Hospital de Laredo, Laredo, Spain., Rios P; Hospital Nuestra Señora de la Candelara, Santa Cruz de Tenerife, Spain., Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Flores-Montero J; Translational and Clinical Research Program, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Department of Medicine, Cytometry Service, Instituto de Investigación Biosanitaria de Salamanca (IBSAL) and CIBER-ONC (number CB16/12/00400), University of Salamanca, Salamanca, Spain., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Department of Medicine, Cytometry Service, Instituto de Investigación Biosanitaria de Salamanca (IBSAL) and CIBER-ONC (number CB16/12/00400), University of Salamanca, Salamanca, Spain., Goldschmidt H; Heidelberg University Clinic Hospital, Department of Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse, Unité 1037, INSERM, Toulouse, France., Roccaro AM; ASST Spedali Civili di Brescia, Brescia, Italy., San-Miguel JF; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Paiva B; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.
Corporate Authors: PETHEMA/GEM and iMMunocell Cooperative Groups
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Nov 01; Vol. 28 (21), pp. 4771-4781.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-22-1594